ALX Oncology Holdings Inc. (ALXO) Financials

ALXO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 242.6 million 52.8 million
2023-09-30 220.1 million 51.4 million
2023-06-30 245.9 million 33.2 million
2023-03-31 278.1 million 37.8 million

ALXO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -39.8 million 6.7 million
2023-09-30 -29.9 million 7.0 million
2023-06-30 -33.5 million 6.2 million
2023-03-31 -28.5 million 6.4 million

ALXO Net Income

No data available :(

ALXO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 182.7 million - 7.6 million
2023-09-30 196.4 million - -
2023-06-30 212.8 million - -
2023-03-31 227.9 million 9.5 million 956000

ALXO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 49.0 million
2023-09-30 41.1 million
2023-06-30 40.9 million
2023-03-31 40.9 million

ALXO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 148000 41.8 million 6.2 million 207000
2023-09-30 1.3 million 45.8 million 7.5 million -
2023-06-30 1.7 million 29.5 million 7.3 million -
2023-03-31 690000 24.8 million 7.4 million -

ALXO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 207000
2023-09-30 - 209000
2023-06-30 - 513000
2023-03-31 - 518000

ALXO

Price: $16.98

52 week price:
3.94
17.42

Earnings Per Share: -3.74 USD

P/E Ratio: -4.38

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 63179

Market Capitalization: 613.4 million

Links: